FFAR2/GPR43 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-09449
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C terminal region of human FFAR2/GPR43 (NP_005297). Peptide sequence LLFYFSSSVVRRAFGRGLQVLRNQGSSLLGRRGKDTAEGTNEDRGVGQGE
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
37 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for FFAR2/GPR43 Antibody
Western Blot: FFAR2/GPR43 Antibody [NBP3-09449]
Western Blot: FFAR2/GPR43 Antibody [NBP3-09449] - Western blot analysis of FFAR2/GPR43 in Human Thyroid Tumor lysates. Antibody dilution at 1ug/mlApplications for FFAR2/GPR43 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FFAR2/GPR43
Long Name
Free Fatty Acid Receptor 2
Alternate Names
GPR43
Gene Symbol
FFAR2
Additional FFAR2/GPR43 Products
Product Specific Notices for FFAR2/GPR43 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...